HESA Committee Report
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Appendix F: List of Witnesses (Women’s Health)
The following table lists the witnesses who appeared before the committee at its meetings related to this report. Transcripts of all public meetings related to this report are available on the committee’s webpage for this study.
Committee Meeting No. 111—HESA (44-1)—Thursday, April 18, 2024
That the committee proceed to the study of breast cancer screening following the study on the opioid epidemic and toxic drug crisis in Canada; that the evidence and documents received as part of the women’s health study be also considered in the committee’s study of breast cancer screening […].
Organizations and Individuals |
Date |
Meeting |
Canadian Institutes of Health Research
|
2023/11/27 |
91 |
|
||
Department of Health
|
2023/11/27 |
91 |
Public Health Agency of Canada
|
2023/11/27 |
91 |
As an individual
|
2023/11/29 |
92 |
EndoAct Canada
|
2023/11/29 |
92 |
McGill University Health Centre
|
2023/11/29 |
92 |
As an individual
|
2023/12/06 |
94 |
Dense Breasts Canada
|
2023/12/06 |
94 |
As an individual
|
2024/02/12 |
101 |
Ovarian Cancer Canada
|
2024/02/12 |
101 |
The Society of Gynecologic Oncology of Canada
|
2024/02/12 |
101 |
As an individual
|
2024/02/15 |
103 |
Canadian Cancer Society
|
2024/02/15 |
103 |
As an individual
|
2024/04/08 |
108 |
Québec Alliance for Perinatal Mental Health
|
2024/04/08 |
108 |
As an individual
|
2024/04/11 |
109 |
Centre for Addiction and Mental Health
|
2024/04/11 |
109 |
Kawartha Sexual Assault Centre
|
2024/04/11 |
109 |
Persons Against Non-State Torture
|
2024/04/11 |
109 |
As an individual
|
2024/05/02 |
113 |
MS Canada
|
2024/05/02 |
113 |